Keywords: genelabs, files, ind, technologies, inc, filed, investigational

GENELABS FILES IND

Article | 25 January 1993

- Genelabs Technologies Inc has filed an Investigational New Drug application in the USA for its GL331, a chemotherapy-resistant tumor therapy.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in